Arctic Bioscience AS (ABS.OL)

NOK 1.9

(-5.0%)

Net Debt Summary of Arctic Bioscience AS

  • Arctic Bioscience AS's latest annual net debt in 2023 was -77.55 Million NOK , up 45.41% from previous year.
  • Arctic Bioscience AS's latest quarterly net debt in 2023 FY was -77.55 Million NOK , up 45.41% from previous quarter.
  • Arctic Bioscience AS reported annual net debt of -142.06 Million NOK in 2022, up 36.9% from previous year.
  • Arctic Bioscience AS reported annual net debt of -225.12 Million NOK in 2021, down -7476.92% from previous year.
  • Arctic Bioscience AS reported quarterly net debt of -130.6 Million NOK for 2023 Q1, up 8.07% from previous quarter.
  • Arctic Bioscience AS reported quarterly net debt of -72.89 Million NOK for 2023 Q4, down 0.0% from previous quarter.

Annual Net Debt Chart of Arctic Bioscience AS (2023 - 2018)

Historical Annual Net Debt of Arctic Bioscience AS (2023 - 2018)

Year Net Debt Net Debt Growth
2023 -77.55 Million NOK 45.41%
2022 -142.06 Million NOK 36.9%
2021 -225.12 Million NOK -7476.92%
2020 -2.97 Million NOK 81.72%
2019 -16.25 Million NOK -239.0%
2018 11.69 Million NOK 0.0%

Peer Net Debt Comparison of Arctic Bioscience AS

Name Net Debt Net Debt Difference
Aqua Bio Technology ASA -5.82 Million NOK -1230.526%
ArcticZymes Technologies ASA -237.27 Million NOK 67.315%
BerGenBio ASA -155.55 Million NOK 50.143%
Hofseth BioCare ASA 112.89 Million NOK 168.693%
PCI Biotech Holding ASA -40.86 Million NOK -89.784%
Thor Medical ASA -41.28 Million NOK -87.853%
Ultimovacs ASA -262.84 Million NOK 70.495%